These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 3629058
21. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar). Selby CD, Ladusans EJ, Smith PG. Br Med J (Clin Res Ed); 1985 Jan 12; 290(6462):113-4. PubMed ID: 3155635 [No Abstract] [Full Text] [Related]
22. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. Centers for Disease Control (CDC). MMWR Morb Mortal Wkly Rep; 1985 Jan 04; 33(51-52):713-4. PubMed ID: 3917533 [No Abstract] [Full Text] [Related]
25. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar). Daniel PT, Holzschuh J, Berg PA. Thorax; 1989 Apr 04; 44(4):307-9. PubMed ID: 2763233 [Abstract] [Full Text] [Related]
26. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis. Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE. Br Med J (Clin Res Ed); 1987 Aug 08; 295(6594):365-6. PubMed ID: 2958104 [No Abstract] [Full Text] [Related]
29. Erythema multiforme (Stevens-Johnson) precipitated by Fansidar. Adams SJ, Broadbent J, Clayden LM, Ridley CM. Postgrad Med J; 1985 Mar 08; 61(713):263-4. PubMed ID: 3983064 [Abstract] [Full Text] [Related]
30. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar). Zitelli BJ, Alexander J, Taylor S, Miller KD, Howrie DL, Kuritsky JN, Perez TH, Van Thiel DH. Ann Intern Med; 1987 Mar 08; 106(3):393-5. PubMed ID: 2949680 [Abstract] [Full Text] [Related]
31. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine. Lenox-Smith I. J Infect; 1987 Jan 08; 14(1):90-2. PubMed ID: 3819463 [No Abstract] [Full Text] [Related]
34. [A case of hypersensitivity type of liver injury induced by pyrimetamine and sulfadoxin (Fansidar)]. Okazaki Y, Watanabe N, Uchiyama J, Nakano A, Nishizaki Y, Kagawa T, Matsuzaki S. Nihon Shokakibyo Gakkai Zasshi; 1997 Feb 08; 94(2):129-32. PubMed ID: 9071177 [No Abstract] [Full Text] [Related]
36. Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. Phillips-Howard PA, West LJ. J R Soc Med; 1990 Feb 08; 83(2):82-5. PubMed ID: 2138674 [Abstract] [Full Text] [Related]
40. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria. JAMA; 1985 Jan 25; 253(4):483. PubMed ID: 3881605 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]